Breadcrumbs Home Media Press Releases Press Releases Press Releases Regulatory Press Releases More Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2021-04-19 08:00Notice of Annual General Meeting in Moberg Pharma AB (publ)Read more 2021-02-10 14:30OncoZenge has been approved for listing on Nasdaq First North Growth MarketRead more 2021-02-09 08:00Moberg Pharmas Year-end report 2020Read more 2021-02-08 16:00Correction regarding ISIN code for the share in the prospectusRead more 2021-02-08 11:00OncoZenge has obtained a conditional approval for listing on Nasdaq First North Growth Market and publishes prospectusRead more 2021-02-02 08:00Moberg Pharma's Year-end report for the financial year 2020 to be published on February 9 - Invitation to teleconferenceRead more Pagination First page Previous page … Page 18 Page 19 Page 20 Page 21 Current page 22 Page 23 Page 24 Page 25 Page 26 … Next page Last page Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2020-03-23 21:00Moberg Pharma enters financing agreement of up to SEK 216 million for further investments in MOB-015Read more 2020-02-11 08:00Moberg Pharma AB Interim report October - December 2019Read more 2020-02-04 08:00Moberg Pharma's Interim report to be published on February 11 - Invitation to teleconferenceRead more 2020-01-22 08:00Expert evaluation clarifies Phase 3 results and provides strong support for MOB-015Read more 2020-01-14 08:30The Swedish Tax Agency has published a notification on distribution of the acquisition cost of shares due to the redemption in 2019 of shares in Moberg Pharma AB for cashRead more 2019-12-12 08:00Moberg Pharma comments on the results of the North American Phase 3 study with MOB-015Read more Pagination First page Previous page … Page 18 Page 19 Page 20 Page 21 Current page 22 Page 23 Page 24 Page 25 Page 26 … Next page Last page
